Impax Receives FDA Approval for Generic Version of Adderall XR(R) (mixed salts of a single-entity amphetamine product) Capsules, CII

HAYWARD, Calif., Feb. 17, 2016 -- (Healthcare Sales & Marketing Network) -- Impax Laboratories, Inc. (IPXL) today announced that the U.S. Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for dextroamphetamine sac... Biopharmaceuticals, Generics, FDAImpax Laboratories, Adderall XR, amphetamine

Source: HSMN NewsFeed - February 17, 2016 Category: Pharmaceuticals Source Type: news